Glioblastoma multiforme (GBM) is a highly aggressive, complex, and devastating form of brain cancer, effecting hundreds of people each day. We believe it is our duty to accelerate progress against this disease so we launched the Defeat GBM Research Collaborative in 2013 with the intent to double the 5 year survival rate of GBM patients. This comes at a time when collaboration is becoming the norm and the abundance of genomic data is accelerating diagnostic, prognostic, and therapeutic progress.
Oligo Research Fund
Oligodendroglioma (oligo) is a relatively rare brain tumor representing about 6% of gliomas, with a diagnosis rate of about 1,150 patients a year in the U.S. alone. Critical research is required to deliver oligo patients new therapies that are more durable and extend their lives. In order to make effective, targeted therapies a reality it is essential to identify and understand the molecular drivers of the tumor’s genesis and maintenance, as well as resistance. You can make a difference by donating directly to the Oligo Research Fund today.
Pediatric Research Initiative
Our Pediatric Research Initiative is now in it’s second phase and funds research designed to better understand how a child’s brain develops during the early years of life. With this foundation of knowledge, researchers can focus on the best biological targets for the development of new therapies that also minimize long-term adverse effects.
The Community Research Fund allows contributors to pool donations to support research on a specific type of tumor. This program leverages a team of highly experienced, nationally-recognized scientific experts, working with National Brain Tumor Society staff, to determine the best investment strategy for each fund.
From the Blog
December 2, 2013
One Person Who Inspires Us This Month: Dr. Lauren Farber – A Tribute
Dr. Lauren Farber was one of those special types of people; the type who could exude both toughness and strength, just as easily as warmth and compassion. Lauren had already dedicated her life to helping sick children as a practicing pediatrician and Partner at the Holliston (Mass.) Pediatric Group, when she was diagnosed with a [...]Read more |
November 25, 2013
SNO-ing: Gathering at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology
The Society for Neuro-Oncology (SNO), the preeminent trade organization for those working in the brain tumor arena, seeks to advance the field through research and education. SNO hosts an annual multi-day meeting that is ‘must-go’ for brain cancer researchers, clinicians, surgeons, patient advocacy organizations, and biopharma industry executives (for which we are proud to continue [...]Read more |
November 21, 2013
National Brain Tumor Society’s First Community Fund to Accelerate Oligodendroglioma Research
Oligodendroglioma Research Fund awards its first grants to fight rare brain tumor Today, the National Brain Tumor Society and Oligo Nation announced that Dr. David Louis, MD, of Massachusetts General Hospital and Harvard Medical School, and Dr. Anders Persson, PhD, of The University of California, San Francisco are the first grant recipients of the Oligodendroglioma [...]Read more |